Genomic Navigators Key to Proper Interpretation of Sequencing Data

August 14, 2014

HemOnc Today covered how advances in genome sequencing are now requiring advanced interpretation and interpreters for patients. For example, the article cites a Genes & Development review by Anil Rustgi, MD, chief of Gastroenterology, that describes subsets of familial pancreatic cancer that involve several types of mutations, but the majority of familial pancreatic cancer cases have yet to have their genetic underpinnings elucidated, waiting in part for the results of deep sequencing efforts. Team approaches ultimately will help clarify the confusion surrounding these and other mutations, said Jennifer Morrissette, PhD, clinical director at the Center for Personalized Diagnostics.

HemOnc Today article